Kkr & CO INC Form 4 insider transactions

Director Timothy R. Barakett reports acquisition of 1,166 restricted stock units of KKR & Co. Inc. and disposal of 150,000 shares held indirectly through a limited partnership.

KKR Group Partnership L.P. reports the sale of 2,948,723 shares of Crescent Energy Co Class A Common Stock at $9.91 per share, along with related conversions of Class B Common Stock and OpCo LLC Units.

KKR Genetic Disorder L.P. sold 6 million shares of BridgeBio Pharma at $32.96 per share.

KKR Alternative Assets LLC acquired 47,995.804 shares of KKR Real Estate Select Trust Inc. common stock at $24.7 per share as payment for management and/or incentive fees.

KKR Alternative Assets LLC acquired 52,975.235 shares of KKR Real Estate Select Trust Inc. common stock as payment for management and incentive fees.

KKR Alternative Assets LLC and related entities acquired 102,613.161 shares of KKR Real Estate Select Trust Inc. as payment for management and incentive fees.

KKR & Co. Inc. director Evan Spiegel was granted 1,238 restricted stock units on December 12, 2024, which will vest on December 1, 2025.

KKR & Co. Inc. director Robert W. Scully was granted 1,238 restricted stock units on December 12, 2024, which will vest on December 1, 2025.

Patricia Russo, a director at KKR & Co. Inc., was granted 1,238 restricted stock units on December 12, 2024, which will vest on December 1, 2025.

Director Kimberly A. Ross of KKR & Co. Inc. reports the acquisition of 1,238 restricted stock units and the disposal of 4,267 common stock shares on December 12, 2024.

KKR & Co. Inc. director Niel Xavier Bruno was granted 1,238 restricted stock units on December 12, 2024, which will vest on December 1, 2025.

KKR & Co. Inc. director Arturo Gutierrez was granted 1,238 restricted stock units on December 12, 2024, which will vest on December 1, 2025.

Director Mary N. Dillon of KKR & Co. Inc. reported the acquisition of 1,238 restricted stock units and the disposal of 4,267 common stock shares held indirectly through a trust.

KKR & Co. Inc. director Matt Cohler was granted 1,238 restricted stock units on December 12, 2024, which will vest on December 1, 2025.

KKR & Co. Inc. director Adriane M. Brown acquired 1,238 restricted stock units on December 12, 2024, which will vest on December 1, 2025.

KKR Alternative Assets LLC and related entities acquired 50,100.064 shares of KKR Real Estate Select Trust Inc. as payment for management and incentive fees.

KKR & Co. Co-Chief Executive Officer Scott Nuttall reported the transfer of shares through grantor retained annuity trusts to family trusts.

KKR Group Partnership L.P. and related entities have sold a significant portion of their OneStream, Inc. holdings following the company's secondary public offering.

KKR & Co. Inc. Co-Chief Executive Officer Joseph Bae reported the transfer of a significant number of common stock shares through trusts in a recent SEC Form 4 filing.

KKR Group Partnership L.P. and related entities have sold a substantial number of AppLovin Corp Class A shares after converting Class B shares, with transactions occurring at various prices on November 21, 2024.

KKR Group Partnership L.P. and related entities have sold a significant portion of their OneStream, Inc. Class A common stock following the company's secondary public offering.

KKR Real Estate Select Trust Inc. issued 51,468.705 shares of common stock to KKR Alternative Assets LLC at a price of $25.21 per share as payment for management and/or incentive fees.

KKR Alternative Assets LLC acquired 104,406.552 shares of KKR Real Estate Select Trust Inc. common stock at $25.32 per share as payment for management and/or incentive fees.

KKR Genetic Disorder L.P. sold 5.8 million shares of BridgeBio Pharma at $25.75 per share on September 13, 2024.

KKR Group Partnership L.P. reports the acquisition of 11,619,998 shares of BrightSpring Health Services at $11.13 per share.

KKR Alternative Assets LLC acquired 51,129.345 shares of KKR Real Estate Select Trust Inc. common stock at $25.39 per share as payment for management and/or incentive fees.

Co-CEO of KKR & Co. Inc., Scott Nuttall, reports changes in beneficial ownership of KKR common stock due to trust transfers.

KKR & Co. Inc. Co-CEO Joseph Bae reported the transfer of common stock to a family trust and other transactions involving grantor retained annuity trusts.

KKR Alternative Assets LLC acquired 51,304.883 shares of KKR Real Estate Select Trust Inc. common stock as payment for management and incentive fees.

KKR Group Partnership L.P. and related entities sold shares of OneStream, Inc. Class A Common Stock at $18.85 per share on July 25, 2024, following the company's initial public offering.